TABLE 1.
Vaccination programs up to 2004 in eight countries participating in the two EUpertstrain projects
| Country | Yrs of vaccination program | Vaccination schedulea | Booster schedulea |
|---|---|---|---|
| Finlandb | 1952 | 3, 4, and 5 mo DTwP | 20 to 24 mo DTwP |
| The Netherlands | 1953 | 2, 3, 4, and 11 mo DTwP-IPV-Hib | |
| France | 1959 | 3, 4, and 5 mo DTwP-IPV | 16 to 8 mo DTwP-IPV |
| 1995 | 2, 3, and 4 mo DTwP-IPV-Hib | 16 to 18 mo DTwP-IPV-Hib | |
| 1998 | 2, 3, and 4 mo DTwP-IPV-Hib | 16 to 18 mo DTaP-IPV-Hib, 11 to 13 yr DtaP-IPV | |
| Germany | 1995 | 2, 3, and 4 mo DTaP-IPV-Hib-HB | 11 to 14 mo DTaP-IPV-Hib-HB |
| 2000 | 2, 3, and 4 mo DTaP-IPV-Hib-HB | 11 to 14 mo DTaP-IPV-Hib-HB, 9 to 17 yr dTaP or dTaP-IPV | |
| Sweden | 1953 | 3, 5, and 12 mo DTwP | |
| 1979-1996 | No vaccination | ||
| 1996 | 3, 5, and 12 mo DTPa | ||
| 1998 | 3, 5, and 12 mo DTaP-IPV-Hib | ||
| Denmark | 1961 | 5, 6, 7, and 15 mo DTwP | |
| 1969 | 5 and 9 wk and 10 mo wP (nonadsorbed) | ||
| 1997 | 3, 5, and 12 mo DTaP-IPV | ||
| 2002 | 3, 5, and 12 mo DTaP-IPV/HIB | ||
| 2003 | 5 yr TdaP | ||
| 2004 | 5 yr Tdap-IPV | ||
| Poland | 1960 | 2, 3 to 4, 5, and 16 to 17 mo DTwP | |
| 2004 | 6 yr DtaP | ||
| United Kingdom | 1950 | 3, 5, and 10 mo DTwP | |
| 1990 | 2, 3, and 4 mo DTwP | ||
| 2000/2001 | DtaP-Hibc | ||
| October 2001 | aP added to preschool DT |
a
The age of the children (in weeks, months, or years) when the vaccine or booster was given and the specific vaccine are shown in the vaccination and booster schedules. Vaccine abbreviations: DTwP, diphtheria-tetanus-whole-cell pertussis; IPV, inactivated poliovirus; Hib, Haemophilus influenzae type b; DTaP, diphtheria-tetanus-acellular pertussis; HB, hepatitis B; wP, whole-cell pertussis; aP, acellular pertussis.
b
For Finland, acellular pertussis vaccine was given to children at 6 years of age starting January 2003.
c
In the United Kingdom, three-component aP was used temporarily in the primary DTaP-Hib vaccine from 2000 to 2001.